XTX Topco’s Pliant Therapeutics PLRX Stock Holding History

XTX Topco’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$503K	Sell	440,844 -59,994	-12%	-$73K	0.01%	2454
2026 Q1	$631K	Sell	500,838 -44,178	-8%	-$55.8K	0.01%	1814
2025 Q4	$665K	Buy	545,016 +78,032	+17%	+$117K	0.02%	1360
2025 Q3	$691K	Buy	466,984 +37,974	+9%	+$57.9K	0.04%	829
2025 Q2	$498K	Sell	429,010 -37,832	-8%	-$53.5K	0.02%	1102
2025 Q1	$630K	Buy	+466,842	New	+$2.83M	0.03%	852
2023 Q4	–	Sell	-11,963	Closed	-$207K	–	2002
2023 Q3	$207K	Sell	11,963 -98	-0.8%	-$1.7K	0.04%	995
2023 Q2	$219K	Buy	+12,061	New	+$286K	0.04%	948
2023 Q1	–	Sell	-13,918	Closed	-$269K	–	1574
2022 Q4	$269K	Buy	+13,918	New	+$291K	0.06%	659
2022 Q3	–	Sell	-15,581	Closed	-$125K	–	1323
2022 Q2	$125K	Buy	15,581 +2,856	+22%	+$18.3K	0.05%	592
2022 Q1	$89K	Buy	+12,725	New	+$130K	0.04%	531

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

XTX Topco's PLRX Position: Q2 2026 in Review

XTX Topco reduced its Pliant Therapeutics (PLRX) stake by 12% in Q2 2026, selling an estimated $73K and leaving 440,844 shares worth $503K. The position accounts for 0.01% of the portfolio, ranked #2454.

XTX Topco first reported a position in PLRX in Q1 2022 and has held it in 11 quarters since. The position peaked at $691K in Q3 2025. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

XTX Topco held 440,844 shares of Pliant Therapeutics worth $503K as of Q2 2026.
XTX Topco sold 59,994 Pliant Therapeutics shares in Q2 2026, an estimated $73K.
Pliant Therapeutics made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2454 holding.
XTX Topco first reported a position in Pliant Therapeutics in Q1 2022 and has held it in 11 quarters since.
XTX Topco's Pliant Therapeutics position peaked at $691K in Q3 2025.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.